CD34 and myelodysplastic syndrome: Another hematologic malignancy, myelodysplastic syndromes (MDS), has been difficult to engraft in NSG mice, but CD34+ HSPCs from MDS patients engrafted well in MISTRG mice [17] (Table 1).